Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally.
Repligen stock last closed at $165.76, down 0.46% from the previous day, and has increased 11.18% in one year. It has overperformed other stocks in the Medical Instruments & Supplies industry by 0.43 percentage points. Repligen stock is currently +60.99% from its 52-week low of $102.97, and -9.18% from its 52-week high of $182.52.
As of Dec 4, 2025, there are 56.29M shares of RGEN outstanding. The market capitalization of RGEN is $9.33B. In the last 24 hours, 599,000 RGEN shares were traded.
How to Buy Repligen Stock
Not sure how to invest in Repligen stock? Here's how.
Choose where to buy Repligen stock: You need to pick an online brokerage, but don't worry - we've researched dozens of online stock brokerages and apps to help you determine where to buy Repligen stock.
Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
Deposit funds into your investment account: Pick your method of payment and add your info.
Research Repligen stock: The Repligen ticker symbol is RGEN. Is Repligen stock a good investment? Should you buy shares of RGEN? How do RGEN's underlying business fundamentals look? Do top analysts think Repligen is a good buy? Why has RGEN's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if RGEN is a good stock to buy).
Place your RGEN buy order: Decide if you will purchase RGEN shares at the current market price or use a limit order to buy RGEN stock at a given price.
Get the latest scoop on your RGEN position: Create a watchlist to get the latest news on your position in Repligen shares.
Step 1: Choose where to buy Repligen stock
You need a brokerage account in order to access the NASDAQ market and buy RGEN stock.
A brokerage account allows you to buy and sell a number of financial instruments, such as stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
Access to global markets: From Tech to Energy, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other financial assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for your brokerage account
Now that you've picked the best brokerage, you need to fill out some personal details so you are able to invest in RGEN today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Research Repligen stock
After you have selected the best place to buy Repligen stock, it's important to analyze their stock before you invest, so you actually comprehend the risk and upside.
Repligen Numbers
RGEN Price
$165.76
1w %
-3.08%
1y %
11.18%
5y %
-11.98%
P/E
8,288x
P/B
4.48x
P/S
13.18x
PEG
20.12x
Revenue
$707.89M
Earnings
$1.74M
Fore. Rev. Growth
10.73%
Fore. Earn. Growth
412.01%
Market Cap
$9.33B
Next Earnings
N/A
Next Dividend
N/A
RGEN Due Diligence Score
WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis.
There are more short-term assets than long-term liabilities on the RGEN balance sheet.
RGEN profit margin has gone up from -1.3% to 0.2% in the past year.
There are more short-term assets than short-term liabilities on the RGEN balance sheet.
Cons:
RGEN has a relatively high debt to equity ratio of 0.4.
Total RGEN debt is higher than 5 years ago, relative to shareholder equity.
RGEN's operating cash flow of $130.89M allows it to safely service it's debt of $688.87M.
RGEN earnings of $26.14M is not sufficient to cover its interest payments.
Is it a good time to buy RGEN stock, according to Wall Street analysts?
Out of 9 sell side analysts who track RGEN, the consensus analyst rating on Repligen is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they financial advice.
Most Recent RGEN Analyst Forecasts
Raghuram Selvaraju, a top 1% analyst from HC Wainwright & Co. reiterates RGEN with a buy rating and maintains their RGEN price target from $180.00 to $180.00, on Sep 3, 2025.
Conor McNamara, a bottom 2% analyst from RBC Capital maintains RGEN with a buy rating and raises their RGEN price target from $193.00 to $204.00, on Jul 30, 2025.
Brandon Couillard, a top 23% analyst from Wells Fargo maintains RGEN with a strong buy rating and lowers their RGEN price target from $180.00 to $175.00, on Jul 30, 2025.
Steven Etoch, a top 47% analyst from Stephens & Co. assumes RGEN with a strong buy rating and announces their RGEN price target of $160.00, on Jul 22, 2025.
Last year, RGEN earnings were $1.74M. Over the past five year, RGEN's earnings have grown by -52.53% per year. This was slower than the Medical Instruments & Supplies industry average of 13.09%.
Last year, RGEN revenue was $707.89M. During the last 5 year, RGEN's revenue has grown by 16.7% per year. This was faster than the Medical Instruments & Supplies industry average of 12.18%.
No, Repligen doesn't provide an income stream by paying out dividends.
What do other traders have to say about RGEN?
One of the major reasons eToro is our favorite brokerage is because of its social trading community.
Click below to find out what other traders have to say.
Step 5: Place your RGEN buy order
You have two primary types of orders:
Market order: A market order is an order to buy or sell a stock at the best price on the market. Market orders are usually fine.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to make sure you're buying or selling at a given price limit, use a limit order.
Click the Open Trade button and eToro will place your order.
If you require more assistance investing in stocks on eToro, watch the helpful video below:
As of Dec 4, 2025, it costs $165.76 to buy one share of Repligen stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $100, you can buy 0.603 shares of RGEN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.